Бюрократы, Администраторы, Редакторы
3712
правок
Mikhail Blagosklonny: различия между версиями
Перейти к навигации
Перейти к поиску
→Editorial activities
Rodion (обсуждение | вклад) |
Rodion (обсуждение | вклад) |
||
| Строка 15: | Строка 15: | ||
== Editorial activities== | == Editorial activities== | ||
Blagosklonny is editor-in-chief of Aging, Cell Cycle, and Oncotarget. In addition, he is associate editor of Cancer Biology & Therapy | Blagosklonny is editor-in-chief of Aging, Cell Cycle, and Oncotarget. In addition, he is associate editor of Cancer Biology & Therapy and a member of the editorial board of Cell Death & Differentiation. | ||
The peer review process employed by Oncotarget has been criticized by Jeffrey Beall,a university librarian and expert on predatory open access publishing, who also included Oncotarget and Aging on his list of "potential, possible, or probable predatory scholarly open-access journals" in July 2015. Further reports on Beall's blog suggest that the substandard peer review processes for these journals are used by their respective editors-in-chief to entice prospective authors to include references to Blagosklonny's own publications in their articles (following the peer review), thereby raising his personal citation impact. | The peer review process employed by Oncotarget has been criticized by Jeffrey Beall,a university librarian and expert on predatory open access publishing, who also included Oncotarget and Aging on his list of "potential, possible, or probable predatory scholarly open-access journals" in July 2015. Further reports on Beall's blog suggest that the substandard peer review processes for these journals are used by their respective editors-in-chief to entice prospective authors to include references to Blagosklonny's own publications in their articles (following the peer review), thereby raising his personal citation impact. | ||